[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA28110A1 - Antagonistes du recepteur d'acetylcholine muscarinique - Google Patents

Antagonistes du recepteur d'acetylcholine muscarinique

Info

Publication number
MA28110A1
MA28110A1 MA28964A MA28964A MA28110A1 MA 28110 A1 MA28110 A1 MA 28110A1 MA 28964 A MA28964 A MA 28964A MA 28964 A MA28964 A MA 28964A MA 28110 A1 MA28110 A1 MA 28110A1
Authority
MA
Morocco
Prior art keywords
antagonists
muscarinic receptor
acetylcholine muscarinic
acetylcholine
receptor antagonists
Prior art date
Application number
MA28964A
Other languages
English (en)
Inventor
Jakob Busch-Petersen
Michael R Palovich
Zehong Wan
Hongxing Yan
Chongjie Zhu
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA28110A1 publication Critical patent/MA28110A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Antagonistes du récepteur d'acétylcholine muscarinique Des antagonistes des récepteurs d'acétylcholine muscariniques et des méthodes pour leur utilisation sont proposés.
MA28964A 2003-10-14 2006-04-25 Antagonistes du recepteur d'acetylcholine muscarinique MA28110A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51100903P 2003-10-14 2003-10-14

Publications (1)

Publication Number Publication Date
MA28110A1 true MA28110A1 (fr) 2006-08-01

Family

ID=34465175

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28964A MA28110A1 (fr) 2003-10-14 2006-04-25 Antagonistes du recepteur d'acetylcholine muscarinique

Country Status (34)

Country Link
US (3) US7276521B2 (fr)
EP (1) EP1677795B1 (fr)
JP (4) JP2007508390A (fr)
KR (3) KR20080065318A (fr)
CN (3) CN101230061A (fr)
AP (3) AP1828A (fr)
AR (1) AR046103A1 (fr)
AT (1) ATE494285T1 (fr)
AU (1) AU2004281724B2 (fr)
BR (1) BRPI0415361A (fr)
CA (1) CA2542657C (fr)
CY (1) CY1111364T1 (fr)
DE (1) DE602004030930D1 (fr)
DK (1) DK1677795T3 (fr)
EA (3) EA013689B1 (fr)
EC (1) ECSP066468A (fr)
ES (1) ES2358673T3 (fr)
HR (1) HRP20110232T1 (fr)
IL (2) IL174843A0 (fr)
IS (1) IS2918B (fr)
MA (1) MA28110A1 (fr)
MX (1) MXPA06004244A (fr)
MY (1) MY143366A (fr)
NO (1) NO20062042L (fr)
NZ (2) NZ546312A (fr)
OA (1) OA13316A (fr)
PE (1) PE20050963A1 (fr)
PL (1) PL1677795T3 (fr)
PT (1) PT1677795E (fr)
SG (1) SG147436A1 (fr)
SI (1) SI1677795T1 (fr)
TW (3) TWI409060B (fr)
UA (2) UA89734C2 (fr)
WO (1) WO2005037280A1 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200519108A (en) * 2003-07-17 2005-06-16 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
NZ546312A (en) * 2003-10-14 2008-09-26 Glaxo Group Ltd Muscarinic acetycholine receptor antagonists
MXPA06004242A (es) * 2003-10-17 2006-06-28 Glaxo Group Ltd Antagonistas del receptor muscarinico de la acetilcolina.
TW200524577A (en) * 2003-11-04 2005-08-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
EP1725236A4 (fr) * 2004-03-11 2009-05-13 Glaxo Group Ltd Nouveaux antagonistes du recepteur de l'acetylcholine muscarinique m3
WO2005095407A1 (fr) * 2004-03-17 2005-10-13 Glaxo Group Limited Antagonistes du recepteur d'acetylcholine muscarinique m3
US20070185148A1 (en) * 2004-03-17 2007-08-09 Glaxo Group Limited M3 muscarinic acetylchoine receptor antagonists
AR050902A1 (es) 2004-04-27 2006-12-06 Glaxo Group Ltd Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
JP2007537261A (ja) * 2004-05-13 2007-12-20 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
US7932247B2 (en) * 2004-11-15 2011-04-26 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
EP1937267A4 (fr) * 2005-08-02 2009-08-26 Glaxo Group Ltd Antagonistes des recepteurs de l' acetylcholine muscarinique m3
JP2009504768A (ja) * 2005-08-18 2009-02-05 グラクソ グループ リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
KR20090003349A (ko) 2006-04-20 2009-01-09 글락소 그룹 리미티드 화합물
GB0611587D0 (en) 2006-06-12 2006-07-19 Glaxo Group Ltd Novel compounds
DK2046787T3 (da) 2006-08-01 2011-07-18 Glaxo Group Ltd Pyrazolo[3,4-B]pyridin-forbindelser, og deres anvendelse som PDE4-inhibitorer
JP5498168B2 (ja) * 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
US20100329996A1 (en) * 2007-09-12 2010-12-30 Glaxo Group Limited Novel Combination of Therapeutic Agents
PE20091552A1 (es) 2008-02-06 2009-10-25 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
TW200946526A (en) 2008-02-06 2009-11-16 Glaxo Group Ltd Dual pharmacophores-PDE4-muscarinic antagonistics
PE20091563A1 (es) 2008-02-06 2009-11-05 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
JP5502858B2 (ja) 2008-06-05 2014-05-28 グラクソ グループ リミテッド Ｐｉ３キナーゼの阻害剤として有用な４−カルボキサミドインダゾール誘導体
US8765743B2 (en) 2008-06-05 2014-07-01 Glaxosmithkline Intellectual Property Development Limited Compounds
WO2010094643A1 (fr) 2009-02-17 2010-08-26 Glaxo Group Limited Dérivés de quinoline et applications associées dans la rhinite et l'urticaire
WO2010097114A1 (fr) * 2009-02-26 2010-09-02 Glaxo Group Limited Nouvelle combinaison d'agents thérapeutiques
PT2400950T (pt) 2009-02-26 2019-08-29 Glaxo Group Ltd Formulações farmacêuticas compreendendo 4-{(1r)-2-[(6-{2-[(2,6-diclorobenzil)oxi]ethoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
EP2406255B1 (fr) 2009-03-09 2015-04-29 Glaxo Group Limited 4-oxadiazol-2-yl-indazoles en tant qu'inhibiteurs des pi3 kinases
EP2406249A1 (fr) 2009-03-10 2012-01-18 Glaxo Group Limited Dérivés d'indole comme inhibiteurs de ikk2
US20120058984A1 (en) 2009-03-17 2012-03-08 Catherine Mary Alder Pyrimidine derivatives used as itk inhibitors
KR101771193B1 (ko) 2009-04-30 2017-09-05 글락소 그룹 리미티드 Ｐｉ3­키나아제 억제제로서 옥사졸 치환된 인다졸
GB0921075D0 (en) * 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
US20120245171A1 (en) 2009-12-03 2012-09-27 Glaxo Group Limited Benzpyrazole derivatives as inhibitors of pi3 kinases
JP2013512878A (ja) 2009-12-03 2013-04-18 グラクソ グループ リミテッド 新規化合物
US20120238571A1 (en) 2009-12-03 2012-09-20 Glaxo Group Limited Indazole derivatives as pi 3-kinase
WO2011110575A1 (fr) 2010-03-11 2011-09-15 Glaxo Group Limited Dérivés de 2-[2-(benzo- ou pyrido-)thiazolylamino]-6- aminopyridine, utiles dans le traitement de maladies respiratoires, allergiques ou inflammatoires
WO2012032067A1 (fr) 2010-09-08 2012-03-15 Glaxo Group Limited Polymorphes et sels de n-[5-[4-(5-{[(2r,6s-2,6-diméthyl-4-morpholinyl]- méthyl}-1,3-oxazol-2-yl)-1h-indazol-6-yl]-2-(méthyloxy)-3-pyridinyl]- méthanesulfonamide
WO2012035055A1 (fr) 2010-09-17 2012-03-22 Glaxo Group Limited Nouveaux composés
GB201018124D0 (en) 2010-10-27 2010-12-08 Glaxo Group Ltd Polymorphs and salts
RU2666963C2 (ru) 2012-04-13 2018-09-13 Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Агрегированные частицы
GB201222679D0 (en) 2012-12-17 2013-01-30 Glaxo Group Ltd Pharmaceutical combination products
CA2923995A1 (fr) 2013-10-17 2015-04-23 Glaxosmithkline Intellectual Property Development Limited Inhibiteur de pi3k pour le traitement d'une maladie respiratoire
WO2015055691A1 (fr) 2013-10-17 2015-04-23 Glaxosmithkline Intellectual Property Development Limited Inhibiteur de pi3k pour le traitement d'une maladie respiratoire
EP3142694A2 (fr) 2014-05-12 2017-03-22 Glaxosmithkline Intellectual Property (No. 2) Limited Compositions pharmaceutiques comprenant danirixin pour traiter des maladies infecteuses
GB201602527D0 (en) 2016-02-12 2016-03-30 Glaxosmithkline Ip Dev Ltd Chemical compounds
EP3497100A1 (fr) 2016-08-08 2019-06-19 GlaxoSmithKline Intellectual Property Development Limited Composés chimiques
GB201706102D0 (en) 2017-04-18 2017-05-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
GB201712081D0 (en) 2017-07-27 2017-09-13 Glaxosmithkline Ip Dev Ltd Chemical compounds
EP4125919A1 (fr) 2020-03-26 2023-02-08 GlaxoSmithKline Intellectual Property Development Limited Inhibiteurs de cathepsine pour la prévention ou le traitement d'infections virales

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800482A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800481A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800478A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
AT298118B (de) 1967-06-08 1972-04-25 Siemens Ag Verfahren zur Umsetzung von Spannungen in digitale Werte und Vorrichtung zur Durchführung des Verfahrens
CY1308A (en) 1979-12-06 1985-12-06 Glaxo Group Ltd Device for dispensing medicaments
ATE23272T1 (de) 1981-07-08 1986-11-15 Draco Ab Pulverinhalator.
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
CA1224992A (fr) 1982-10-08 1987-08-04 Robert E. Newell Dispositif pour l'administration d'un medicament a un patient
IE59026B1 (en) 1985-07-30 1993-12-15 Glaxo Group Ltd Devices for administering medicaments to patients
IT1204826B (it) 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators
GB9000304D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Muscarinic receptor antagonists
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
JP3294961B2 (ja) * 1993-12-10 2002-06-24 杏林製薬株式会社 新規イミダゾール誘導体及びその製造法
JPH08291141A (ja) * 1995-04-21 1996-11-05 Kotobuki Seiyaku Kk ジフェニル酢酸誘導体及びその製造法
JPH0920758A (ja) * 1995-07-06 1997-01-21 Kyorin Pharmaceut Co Ltd 新規環状ジアミン誘導体及びその製造法
US6350758B1 (en) 1996-12-02 2002-02-26 Georgetown University Tropane derivatives and method for their synthesis
US6248752B1 (en) 1998-02-27 2001-06-19 Charles Duane Smith Azabicyclooctane compositions and methods for enhancing chemotherapy
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CN1571787A (zh) * 2001-10-17 2005-01-26 Ucb公司 奎宁环衍生物、制备它们的方法和它们作为m2和/或m3毒蕈碱受体抑制剂的用途
US6696462B2 (en) 2002-01-31 2004-02-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
DE10211700A1 (de) * 2002-03-16 2003-09-25 Boehringer Ingelheim Pharma Neue Difurylglykolsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
AR040779A1 (es) 2002-08-06 2005-04-20 Glaxo Group Ltd Compuesto de tiazol anilina su uso para preparar una formulacion farmaceutica dicha formulacion recipiente que la contiene y dispositivo adaptado para la administracion intranasal de la formulacion
US7232841B2 (en) 2003-04-07 2007-06-19 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
TW200519109A (en) 2003-07-17 2005-06-16 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
TW200519108A (en) 2003-07-17 2005-06-16 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
PE20050327A1 (es) 2003-07-17 2005-06-08 Glaxo Group Ltd Derivados de 8-azoniabiciclo[3.2.1]octano como antagonistas de los receptores muscarinicos de la acetilcolina
NZ546312A (en) * 2003-10-14 2008-09-26 Glaxo Group Ltd Muscarinic acetycholine receptor antagonists
TW200524577A (en) * 2003-11-04 2005-08-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
DE602004021959D1 (de) 2003-11-21 2009-08-20 Theravance Inc Verbindungen mit agonistischer wirkung am beta2-adrenergen rezeptor und am muscarinischen rezeptor
WO2006050239A2 (fr) 2004-10-29 2006-05-11 Glaxo Group Limited Antagonistes des recepteurs de l'acetylcholine muscarinique
US20090142279A1 (en) 2004-11-15 2009-06-04 Budzik Brian W Novel m3 muscarinic acetylcholine receptor antagonists
US7932247B2 (en) 2004-11-15 2011-04-26 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
PE20061162A1 (es) 2004-12-06 2006-10-14 Smithkline Beecham Corp Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos
PE20060826A1 (es) 2004-12-06 2006-10-08 Smithkline Beecham Corp Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende
WO2006065755A2 (fr) 2004-12-13 2006-06-22 Glaxo Group Limited Sels d'ammonium quaternaire d'amines heteroaromatiques fusionnees utilises comme nouveaux antagonistes du recepteur de l'acetylcholine muscarinique
WO2006065788A2 (fr) 2004-12-13 2006-06-22 Glaxo Group Limited Nouveaux antagonistes du recepteur muscarinique de l'acetylcholine
WO2007018508A1 (fr) 2005-07-28 2007-02-15 Glaxo Group Limited Nouveaux antagonistes du récepteur muscarinique m3 de l’acétylcholine
WO2007018514A1 (fr) 2005-07-28 2007-02-15 Glaxo Group Limited Nouveaux antagonistes récepteurs d’acétylcholine muscarinique m3
EP1937267A4 (fr) 2005-08-02 2009-08-26 Glaxo Group Ltd Antagonistes des recepteurs de l' acetylcholine muscarinique m3
WO2007016650A2 (fr) 2005-08-02 2007-02-08 Glaxo Group Limited Antagonistes du recepteur d'acetylcholine muscarinique m3
JP2009504768A (ja) 2005-08-18 2009-02-05 グラクソ グループ リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト

Also Published As

Publication number Publication date
DK1677795T3 (da) 2011-04-18
JP2007277276A (ja) 2007-10-25
EA013435B1 (ru) 2010-04-30
EP1677795B1 (fr) 2011-01-05
EP1677795A4 (fr) 2006-12-27
NO20062042L (no) 2006-05-08
ATE494285T1 (de) 2011-01-15
DE602004030930D1 (de) 2011-02-17
SI1677795T1 (sl) 2011-04-29
AR046103A1 (es) 2005-11-23
IL188112A (en) 2012-10-31
EP1677795A1 (fr) 2006-07-12
CN101230061A (zh) 2008-07-30
US7276521B2 (en) 2007-10-02
IS2918B (is) 2015-01-15
JP5450509B2 (ja) 2014-03-26
EA200600773A1 (ru) 2008-04-28
EA200702619A1 (ru) 2008-04-28
WO2005037280A1 (fr) 2005-04-28
KR20080065318A (ko) 2008-07-11
US7576096B2 (en) 2009-08-18
TWI409060B (zh) 2013-09-21
JP4796552B2 (ja) 2011-10-19
ECSP066468A (es) 2006-11-16
MY143366A (en) 2011-04-29
US20070105895A1 (en) 2007-05-10
HRP20110232T1 (hr) 2011-05-31
PT1677795E (pt) 2011-04-01
AP2007004239A0 (en) 2007-12-31
TW200811172A (en) 2008-03-01
EA200702617A1 (ru) 2008-04-28
IL174843A0 (en) 2006-08-20
CA2542657C (fr) 2011-03-01
ES2358673T3 (es) 2011-05-12
AP1828A (en) 2008-02-13
TW200522933A (en) 2005-07-16
SG147436A1 (en) 2008-11-28
NZ556424A (en) 2008-12-24
US7579361B2 (en) 2009-08-25
KR20080067023A (ko) 2008-07-17
US20070244150A1 (en) 2007-10-18
JP2007508390A (ja) 2007-04-05
US20070238752A1 (en) 2007-10-11
CN101230062A (zh) 2008-07-30
IS8441A (is) 2006-05-05
CA2542657A1 (fr) 2005-04-28
EA009899B1 (ru) 2008-04-28
JP2007314567A (ja) 2007-12-06
TW200811171A (en) 2008-03-01
OA13316A (en) 2007-04-13
UA89734C2 (en) 2010-02-25
UA87473C2 (en) 2009-07-27
BRPI0415361A (pt) 2006-12-12
EA013689B1 (ru) 2010-06-30
CN1893948A (zh) 2007-01-10
AP2007004238A0 (en) 2007-12-31
NZ546312A (en) 2008-09-26
KR20060106821A (ko) 2006-10-12
CY1111364T1 (el) 2015-08-05
MXPA06004244A (es) 2006-06-28
PE20050963A1 (es) 2006-01-11
JP2011162556A (ja) 2011-08-25
PL1677795T3 (pl) 2011-05-31
AP2006003566A0 (en) 2006-04-30
AU2004281724B2 (en) 2010-07-15
AU2004281724A1 (en) 2005-04-28
IL188112A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
MA28110A1 (fr) Antagonistes du recepteur d&#39;acetylcholine muscarinique
MA27900A1 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
MA27901A1 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
MA28109A1 (fr) Antagonistes du recepteur acetylcholine muscarinique
MA27973A1 (fr) Antagonistes du recepteur de l&#39;acetylcholine muscarinique
MA28218A1 (fr) Nouveaux antagonistes de recepteur d&#39;acetylcholine muscarinique m3
MA28217A1 (fr) Nouveaux antagonistes de recepteur d&#39;acetylcholine muscarinique m3
MY144753A (en) Muscarinic acetylcholine receptor antagonists
CY1113295T1 (el) Ανταγωνιστες m3 μουσκαρινικου υποδοχεα ακετυλοχολινης
MA28363A1 (fr) Antagonistes des recepteurs muscariniques de l&#39;acetylcholine
GB0504828D0 (en) Therapeutic agents
ATE496892T1 (de) Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
TW200633706A (en) Medical combinations
TW200600500A (en) M3 muscarinic acetylcholine receptor antagonists
TW200606161A (en) Muscarinic acetylcholine receptor antagonists
FR2873932B1 (fr) Equipement pour l&#39;apprentissage du putting